Cargando…

Functional Implications of the Dynamic Regulation of EpCAM during Epithelial-to-Mesenchymal Transition

Epithelial cell adhesion molecule (EpCAM) is a transmembrane glycoprotein expressed in epithelial tissues. EpCAM forms intercellular, homophilic adhesions, modulates epithelial junctional protein complex formation, and promotes epithelial tissue homeostasis. EpCAM is a target of molecular therapies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brown, Taylor C., Sankpal, Narendra V., Gillanders, William E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301972/ https://www.ncbi.nlm.nih.gov/pubmed/34209658 http://dx.doi.org/10.3390/biom11070956

Ejemplares similares

Cytosolic EpCAM cooperates with H-Ras to regulate epithelial to mesenchymal transition through ZEB1
por: Omar, Fatma A., et al.
Publicado: (2023)

Activator protein 1 (AP-1) contributes to EpCAM-dependent breast cancer invasion
por: Sankpal, Narendra V, et al.
Publicado: (2011)

Cancer-associated mutations reveal a novel role for EpCAM as an inhibitor of cathepsin-L and tumor cell invasion
por: Sankpal, Narendra V., et al.
Publicado: (2021)

The detection of EpCAM(+) and EpCAM(–) circulating tumor cells
por: Wit, Sanne de, et al.
Publicado: (2015)

Absence of EpCAM in cervical cancer cells is involved in sluginduced epithelial‐mesenchymal transition
por: Liu, Xian, et al.
Publicado: (2021)

Expression of EpCAM(MF) and EpCAM(MT) variants in human carcinomas
por: Fong, Dominic, et al.
Publicado: (2014)

EpCAM Knockdown Alters MicroRNA Expression in Retinoblastoma- Functional Implication of EpCAM Regulated MiRNA in Tumor Progression
por: Beta, Madhu, et al.
Publicado: (2014)

Correction: EpCAM Knockdown Alters MicroRNA Expression in Retinoblastoma- Functional Implication of EpCAM Regulated MiRNA in Tumor Progression
Publicado: (2015)

Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition
por: Gorges, Tobias M, et al.
Publicado: (2012)

Clinicopathology of EpCAM and EGFR in Human Epithelial Ovarian Carcinoma
por: Zheng, Jingying, et al.
Publicado: (2017)

Expression of EpCAM in uveal melanoma
por: Odashiro, Danilo N, et al.
Publicado: (2006)

Biology and clinical relevance of EpCAM
por: Keller, Laura, et al.
Publicado: (2019)

EpCAM as Modulator of Tissue Plasticity
por: Fagotto, François
Publicado: (2020)

EpCAM(high) and EpCAM(low) circulating tumor cells in metastatic prostate and breast cancer patients
por: de Wit, Sanne, et al.
Publicado: (2018)

EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex
por: Subramanian, Nithya, et al.
Publicado: (2015)

Current View on EpCAM Structural Biology
por: Gaber, Aljaž, et al.
Publicado: (2020)

Evolution of Thyroglobulin Loop Kinetics in EpCAM
por: Chen, Serena H., et al.
Publicado: (2021)

Epithelial Mesenchymal Transition and Pancreatic Tumor Initiating CD44+/EpCAM+ Cells Are Inhibited by γ-Secretase Inhibitor IX
por: Palagani, Vindhya, et al.
Publicado: (2012)

EpCAM proteolysis: new fragments with distinct functions?
por: Schnell, Ulrike, et al.
Publicado: (2013)

Functions of EpCAM in physiological processes and diseases (Review)
por: Huang, Li, et al.
Publicado: (2018)

EpCAM expression in squamous cell carcinoma of the uterine cervix detected by monoclonal antibody to the membrane-proximal part of EpCAM
por: Chantima, Warangkana, et al.
Publicado: (2017)

Correction to: EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex
por: Subramanian, Nithya, et al.
Publicado: (2020)

Dataset and analysis of molecular dynamics simulation of EpCAM ectodomain dimer
por: Pavšič, Miha
Publicado: (2021)

EpCAM Aptamer-siRNA Chimera Targets and Regress Epithelial Cancer
por: Subramanian, Nithya, et al.
Publicado: (2015)

Clipping EpCAM to release Claudin-7 for the greater good of the epithelial barrier
por: Varadarajan, Saranyaraajan, et al.
Publicado: (2022)

EpCAM-targeting CAR-T cell immunotherapy is safe and efficacious for epithelial tumors
por: Li, Dan, et al.
Publicado: (2023)

Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer
por: Hyun, Kyung-A, et al.
Publicado: (2016)

EpCAM and the biology of hepatic stem/progenitor cells
por: Dollé, Laurent, et al.
Publicado: (2014)

Targeting EpCAM (CD326) for immunotherapy in hepatoblastoma
por: Armeanu-Ebinger, Sorin, et al.
Publicado: (2013)

Revisiting the Roles of Pro-Metastatic EpCAM in Cancer
por: Mohtar, M. Aiman, et al.
Publicado: (2020)

Improved ovarian cancer EMT-CTC isolation by immunomagnetic targeting of epithelial EpCAM and mesenchymal N-cadherin
por: Po, Joseph W, et al.
Publicado: (2018)

EpCAM expression negatively regulates E-cadherin function in colorectal carcinomas
por: Ezenkwa, Uchenna Simon, et al.
Publicado: (2023)

EpCAM promotes endosomal modulation of the cortical RhoA zone for epithelial organization
por: Gaston, Cécile, et al.
Publicado: (2021)

EpCAM (CD326) finding its role in cancer
por: Baeuerle, P A, et al.
Publicado: (2007)

EpCAM (CD326) finding its role in cancer
por: Baeuerle, P A, et al.
Publicado: (2007)

Expression of EpCam and Villin in Barrett’s Esophagus and in Gastric Cardia
por: Anders, Mario, et al.
Publicado: (2008)

Selection and targeting of EpCAM protein by ssDNA aptamer
por: Alshaer, Walhan, et al.
Publicado: (2017)

EpCAM Immunotherapy versus Specific Targeted Delivery of Drugs
por: Macdonald, Joanna, et al.
Publicado: (2018)

EpCAM(low) Circulating Tumor Cells: Gold in the Waste
por: Nicolazzo, Chiara, et al.
Publicado: (2019)

EpCAM tumor specificity and proteoform patterns in urothelial cancer
por: Dressler, Franz F., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3rqf0r097s4lomuff6japv2vfk